Refers to a compound of formula (i) that can be in the form of Basis, hydrate or solvate and in combination with Prednisone preferably is in the form of acetone solvate and contains between 5% and 8% by weight of acetone. It also relates to a Pharmaceutical composition. This Compound is useful in the treatment of metastatic Prostate CancerSE REFIERE AL COMPUESTO DE FORMULA (I) QUE PUEDE ESTAR EN FORMA DE BASE, HIDRATO O SOLVATO Y EN COMBINACION CON PREDNISONA PREFERIBLEMENTE SE PRESENTA EN FORMA DE SOLVATO DE ACETONA Y CONTIENE ENTRE 5% Y 8% EN PESO DE ACETONA. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO ES UTIL EN EL TRATAMIENTO DEL CANCER DE PROSTATA METASTASICO
